Elin F. Borgen

Nydalen, 0424, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Journal: Cancers

Published: March 25, 2026

Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.

Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.

Journal: Clinical breast cancer

Published: March 17, 2025

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Journal: Communications medicine

Published: October 20, 2024

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.

Journal: Molecular oncology

Published: February 14, 2024

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).

Journal: ESMO open

Published: January 18, 2024

Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.

Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.

Journal: Cancers

Published: September 03, 2022

Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer.

Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer.

Journal: Cancers

Published: October 30, 2021

Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.

Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2021

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer.

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer.

Journal: Nature communications

Published: February 25, 2021

Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.

Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.

Journal: Oncoimmunology

Published: January 18, 2021

Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer.

Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer.

Journal: Cancers

Published: December 21, 2020

Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen.

Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen.

Journal: Molecular oncology

Published: October 05, 2020

Showing 1-12 of 54

Last Updated: 09/26/2026